Hearings, Meetings, Proceedings, etc.: Cellular, Tissue, and Gene Therapies Advisory Committee; Biologics License Application 125827, from Replimune, Inc. for vusolimogene oderparepvec

Title

Hearings, Meetings, Proceedings, etc.: Cellular, Tissue, and Gene Therapies Advisory Committee; Biologics License Application 125827, from Replimune, Inc. for vusolimogene oderparepvec

Posted

Jul 8, 2026

Comment period

Jul 8, 2026 – ?

Agency

Food and Drug Administration (FDA)

FR Doc

2026-13810

Topics

• Animal Health & Welfare
• Healthcare Costs & Access
• Pharmaceutical Policy
• Product Safety & Recalls
• Public Health Infrastructure & Data

No comments yet.